Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111770917B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111770917B details a novel asymmetric route for Factor XIa inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.